About the Authors

Petra Massoner

Contributed equally to this work with: Petra Massoner, Karl G. Kugler

Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)

Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

Karl G. Kugler

Contributed equally to this work with: Petra Massoner, Karl G. Kugler

Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

Karin Unterberger

Affiliation Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

Ruprecht Kuner

Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

Laurin A. J. Mueller

Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

Maria Fälth

Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

Georg Schäfer

Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria

Christof Seifarth

Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria

Simone Ecker

Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

Irmgard Verdorfer

Affiliation Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria

Armin Graber

Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

Holger Sültmann

Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

Helmut Klocker

Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)

Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

Competing Interests

The authors have read the journal’s policy and have the following conflicts: after discussing with Oncotyrol, Center for Personalized Cancer Medicine GmbH, the authors would like to disclose the following: PM, KU and HK conducted this work as employees/associates of Oncotyrol GmbH. The work to this project was co-funded by Oncotyrol GmbH in the context of the Austrian COMET funding program. Oncotyrol GmbH does not plan to file a patent or commercially pursue the results contained in this manuscript. Consequently no competing interest could be identified in the context of the described work. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: PM KK AG HS HK. Performed the experiments: PM KK KU RK LM MF GS CS SE IV HK. Analyzed the data: PM KK RK LM MF GS AG HS HK. Contributed reagents/materials/analysis tools: PM KK RK GS AG HS HK. Wrote the paper: PM KK HK.